Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids

Pei-An Liao1 Institute of Hospital and Health Care Administration, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanView further author information

Sheng-Wei Pan2 Department of Chest Medicine, Taipei Veterans General Hospital, Taipei, Taiwan;3 Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanView further author information

Chun-Yu Chen4 Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;5 Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, TaiwanView further author information

Chung-Yeh Deng1 Institute of Hospital and Health Care Administration, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;4 Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, TaiwanView further author information

Yaa-Hui Dong1 Institute of Hospital and Health Care Administration, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;4 Institute of Public Health, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan;5 Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei, TaiwanCorrespondence[email protected]

https://orcid.org/0000-0001-5336-4113 View further author information

Citations (1)

Keep up to date with the latest research on this topic with citation updates for this article.

Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids

Articles from other publishers (1)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Prescription Patterns of New Use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids

Citations (1)

Articles from other publishers (1)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date